Year: 2025
THIS DOCUMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014.
Press release
Amsterdam, 13 October 2025 at 07:00 CEST
Azerion Group N.V. completes refinancing of outstanding senior secured floating rate bonds maturing in October 2026
Azerion Group N.V. is pleased to confirm the completion of the refinancing of its outstanding senior secured bonds maturing in October 2026 with ISIN NO0013017657 (the “Existing Bonds“), with the successful early redemption of all outstanding Existing Bonds.
For further information, please contact:
Contact: Andrew Buckman – Chief Growth Officer
ir@azerion.com
Media
press@azerion.com
About Azerion
Founded in 2014, Azerion (EURONEXT: AZRN) is one of Europe’s largest...
Corbion reports the progress of its share buyback program 6 October – 10 October 2025
Written by Customer Service on . Posted in Public Companies.
Corbion hereby reports the transaction details related to its share buyback program announced on 1 September 2025.
During the week of 6 October up to and including 10 October 2025 a total of 35.578 shares were repurchased at an average price of €16.7661 for a total amount of €596,504.09
To date, the total consideration for shares repurchased amounts to €4,525,155.64 representing 45.25% of the overall share buyback program.
Corbion publishes on a weekly basis every Monday, an overview of the progress of the share buyback program on its website: https://www.corbion.com/Investor-relations/shareholder-information
This overview contains detailed information on the daily amount of repurchased shares and individual share purchase transactions.Attachment2025 SBB weekly update 20251010
Roche data at ESMO 2025 showcase advances in science and cancer care across multiple tumour types
Written by Customer Service on . Posted in Public Companies.
Basel, 13 October 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present more than 30 abstracts across more than 10 cancer types at the European Society for Medical Oncology (ESMO) Congress 2025, held 17-21 October 2025 in Berlin, Germany. The data underscore Roche’s commitment to deliver transformative medicines for some of the most challenging cancer types, including breast cancers, lung cancers, gastrointestinal and genitourinary cancers.
Key presentations include:Giredestrant: Primary results from the phase III evERA Breast Cancer study, the first positive head-to-head phase III trial investigating a selective oestrogen receptor (ER) degrader-containing regimen versus a standard of care combination in the post-cyclin-dependent kinase inhibitor setting for people with ER-positive, human epidermal growth...
VGP Acquires Site of Former Paper Mill in Hagen, Near Dortmund, to Develop Business Park
Written by Customer Service on . Posted in Public Companies.
The company acquires the approximately 280,000 m² site of the former Kabel Premium Pulp & Paper GmbH
First plot acquisition of VGP in North Rhine-Westphalia, 20 minutes from the centre of Dortmund
VGP plans to develop a modern business and industrial park13 October 2025, 7:00am, Antwerp, Belgium /Düsseldorf, Germany: VGP, a pan-European developer, manager and owner of high-quality logistics and semi-industrial real estate as well as a provider of renewable energy solutions, has acquired the former factory site of Kabel Premium Pulp & Paper GmbH in Hagen. The property covers around 280,000 square metres and was sold to VGP on 9 October 2025 by the insolvency administrator as part of the insolvency proceedings opened in June 2025.
The traditional paper mill had been based at the Hagen site for almost 130 years. The city of Hagen,...
Share repurchase programme: Transactions of week 41 2025
Written by Customer Service on . Posted in Public Companies.
The share repurchase programme runs as from 26 February 2025 and up to and including 30 January 2026 at the latest. In this period, Jyske Bank will acquire shares with a value of up to DKK 2.25 billion, cf. Corporate Announcement No. 3/2025 of 26 February 2025. The share repurchase programme is initiated and structured in compliance with the EU Commission Regulation No. 596/2014 of 16 April 2014, the so-called “Market Abuse Regulation”, and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the “Safe Harbour Rules”).
The following transactions have been made under the program:
Number of shares
Average purchase price (DKK)
Transaction value (DKK)Accumulated, previous announcement
2,141,532
609.38
1,305,001,0636 October 2025
4,500
710.20
3,195,8917 October...
Q3 2025 Qualitative Update: Tecan reports mid-single-digit local currency growth in the third quarter and confirms full-year 2025 outlook
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules
Q3 2025 Qualitative Update: Tecan reports mid-single-digit local currency growth in the third quarter and confirms full-year 2025 outlook
Männedorf, Switzerland, October 13, 2025 – The Tecan Group (SIX Swiss Exchange: TECN) today provided a qualitative update on its performance for the third quarter of 2025.Sales for the third quarter increased by a mid-single-digit percentage in local currencies, representing a further sequential improvement after a mid-single-digit decline in Q1 and a low-single-digit decline in Q2. At the segment level, the Life Sciences Business recorded a low-single-digit sales decline and the Partnering Business achieved a sales increase in the low teens percentage range, both in local currencies and in line with expectations....
HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress
Written by Customer Service on . Posted in Public Companies.
The fruquintinib and sintilimab combination demonstrated significant PFS improvements in advanced renal cell carcinoma patients after progression on first-line therapies
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Oct. 13, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) announces results from the FRUSICA-2 registration clinical trial of the fruquintinib and sintilimab combination for the treatment of patients with locally advanced or metastatic renal cell carcinoma. Results of the Phase III part of the study will be presented on Friday, October 17, 2025 during the European Society for Medical Oncology (“ESMO”) Congress in Berlin, Germany.
FRUSICA-2 is a randomized, open-label, active-controlled registration study evaluating the efficacy and safety of fruquintinib in combination with...
Okeanis Eco Tankers Corp. – Director Resignations
Written by Customer Service on . Posted in Public Companies.
ATHENS, Greece, Oct. 13, 2025 (GLOBE NEWSWIRE) — Okeanis Eco Tankers Corp. (“OET” or the “Company”) (NYSE:ECO / OSE:OET) today announced that each of Robert Knapp and Joshua Nemser have decided to resign as directors of the Company, effective October 10, 2025. The two resignations did not result from any disagreement with the Company or its management.
The board of directors of the Company has not yet determined whether to reduce the size of the board or to fill the relevant vacancies.
The board of directors remains comprised of a majority of independent directors. The composition of each of the committees of the board of directors remains the same and is unaffected by these resignations, except for the remuneration committee, which remains comprised of Charlotte Stratos and Francis “Frank” Dunne.
Ioannis Alafouzos, Chairman of...
Market Alert: AlphaTON Capital Continues in Growth Mode and Purchases an additional 300,000 TON
Written by Customer Service on . Posted in Public Companies.
Dover, DE, Oct. 12, 2025 (GLOBE NEWSWIRE) — AlphaTON Capital Corp. (Nasdaq: ATON) stated that during the market conditions of the past week, AlphaTON Capital is still expanding its TON Treasury, purchasing an additional 300,000 TON off the open market today, adding to the 1.1million TON purchased off the open market last week. With zero liquidations and the majority of its TON assets unencumbered, AlphaTON Capital maintains a debt-to-equity ratio of 0.07.
“AlphaTON Capital is continuing to grow its market share in TON while maintaining prudent asset management policies in volatile market conditions.” Enzo Villani, Chief Investment Officer, stated, “Volatility in the markets has been a reality across all trading exchanges since the beginning of market systems. Our team is focused on managing risk and maintaining proper leverage...
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: Recent Developments Include FX Signing a Deposit Agreement for 1,000 FX Super One MPV’s with ZEVO, a Pioneer of Peer-to-Peer EV Sharing Platform in the U.S.
Written by Customer Service on . Posted in Public Companies.
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: Recent Developments Include FX Signing a Deposit Agreement for 1,000 FX Super One MPV’s with ZEVO, a Pioneer of Peer-to-Peer EV Sharing Platform in the U.S.Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: Recent Developments Include FX Signing a Deposit Agreement for 1,000 FX Super One MPV’s with ZEVO, a Pioneer of Peer-to-Peer EV Sharing Platform in the U.S.ZEVO deposit agreement represents another innovative breakthrough in the Company’s B2B2C sales model, following the car rental, FX Par, real estate brokerage, and MCN agencies.
FF Announced Pinnacle Real Estate Group President Calvin Gong as the latest FF 91 2.0 Futurist Alliance Co-Creation Officer at a ceremony in Los Angeles on Oct. 8.LOS ANGELES, Oct. 12, 2025 (GLOBE NEWSWIRE)...